FIBRINOGEN - IS BENEFIT WORTH RISK

[1] COMPLICATIONS DURING FIBRINOGEN THERAPY IN CASE OF ABRUPTIO PLACENTAE [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1964, 43 (02) : 129 - &

[2] CLINICAL USE OF DRIED FIBRINOGEN (HUMAN) AND RISK OF TRANSMITTING HEPATITIS BY ITS ADMINISTRATION [J]. TRANSFUSION, 1966, 6 (03) : 234 - &

[3] BACHMANN F, 1971, Hospital Practice, V6, P113

[4] Barker L F, 1974, Dev Biol Stand, V27, P178

[5] BICK RL, 1976, TRANSFUSION, V16, P361

[6] BLOMBACK B, 1956, ARK KEMI, V10, P415

[7] BRITTIN GM, 1972, AM J CLIN PATHOL, V57, P89

[8] CLAUSS A., 1957, ACTA HAEMATOL, V17, P237

[9] PREPARATION AND PROPERTIES OF SERUM AND PLASMA PROTEINS .4. A SYSTEM FOR THE SEPARATION INTO FRACTIONS OF THE PROTEIN AND LIPOPROTEIN COMPONENTS OF BIOLOGICAL TISSUES AND FLUIDS [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1946, 68 (03) : 459 - 475

[10] ELLIS BC, 1961, J LAB CLIN MED, V58, P477

[1] COMPLICATIONS DURING FIBRINOGEN THERAPY IN CASE OF ABRUPTIO PLACENTAE [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1964, 43 (02) : 129 - &

[2] CLINICAL USE OF DRIED FIBRINOGEN (HUMAN) AND RISK OF TRANSMITTING HEPATITIS BY ITS ADMINISTRATION [J]. TRANSFUSION, 1966, 6 (03) : 234 - &

[3] BACHMANN F, 1971, Hospital Practice, V6, P113

[4] Barker L F, 1974, Dev Biol Stand, V27, P178

[5] BICK RL, 1976, TRANSFUSION, V16, P361

[6] BLOMBACK B, 1956, ARK KEMI, V10, P415

[7] BRITTIN GM, 1972, AM J CLIN PATHOL, V57, P89

[8] CLAUSS A., 1957, ACTA HAEMATOL, V17, P237

[9] PREPARATION AND PROPERTIES OF SERUM AND PLASMA PROTEINS .4. A SYSTEM FOR THE SEPARATION INTO FRACTIONS OF THE PROTEIN AND LIPOPROTEIN COMPONENTS OF BIOLOGICAL TISSUES AND FLUIDS [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1946, 68 (03) : 459 - 475

[10] ELLIS BC, 1961, J LAB CLIN MED, V58, P477